Epidemiological and twin studies have consistently demonstrated a strong genetic component to prostate cancer (PCa) susceptibility. To date, numerous linkage studies have been performed to identify chromosomal regions containing PCa susceptibility genes. Unfortunately, results from these studies have failed to form any obvious consensus regarding which regions are most likely to contain genes that may contribute to PCa predisposition. One plausible explanation for the difficulty in mapping susceptibility loci is the existence of considerable heterogeneity in the phenotype of PCa, with significant variation in clinical stage and grade of disease even among family members. To address this issue, we performed a genome-wide linkage scan on 71 i...
Abstract: Background: Genetic variants are likely to contribute to a portion of prostate cancer risk...
Abstract: Background: Genetic variants are likely to contribute to a portion of prostate cancer risk...
Introduction Prostate cancer (PrCa) is the commonest non-cutaneous cancer in men in the UK. Epidemio...
BACKGROUND Prostate cancer linkage studies have been used to localize rare and presumably highly pe...
Prostate cancer linkage studies have been used to localize rare and presumably highly penetrant canc...
Prostate cancer linkage studies have been used to localize rare and presumably highly penetrant canc...
Evidence of the existence of major prostate cancer (PC)–susceptibility genes has been provided by mu...
Evidence of the existence of major prostate cancer (PC)–susceptibility genes has been provided by mu...
Prostate cancer represents a significant worldwide public health burden. Epidemiological and genetic...
Prostate cancer is the most frequent cancer among men in most developed countries, yet little is kno...
Background Prostate cancer (PC) is generally believed to have a strong inherited component, but the ...
BACKGROUND Prostate cancer (PC) is generally believed to have a strong inherited component, but the...
Recent studies suggest that hereditary prostate cancer is a complex disease involving multiple susce...
The aggressiveness of prostate cancer (PCa) varies widely: some tumors progress to invasive, potenti...
Background: Prostate cancer represents a substantial public health burden worldwide. It is the secon...
Abstract: Background: Genetic variants are likely to contribute to a portion of prostate cancer risk...
Abstract: Background: Genetic variants are likely to contribute to a portion of prostate cancer risk...
Introduction Prostate cancer (PrCa) is the commonest non-cutaneous cancer in men in the UK. Epidemio...
BACKGROUND Prostate cancer linkage studies have been used to localize rare and presumably highly pe...
Prostate cancer linkage studies have been used to localize rare and presumably highly penetrant canc...
Prostate cancer linkage studies have been used to localize rare and presumably highly penetrant canc...
Evidence of the existence of major prostate cancer (PC)–susceptibility genes has been provided by mu...
Evidence of the existence of major prostate cancer (PC)–susceptibility genes has been provided by mu...
Prostate cancer represents a significant worldwide public health burden. Epidemiological and genetic...
Prostate cancer is the most frequent cancer among men in most developed countries, yet little is kno...
Background Prostate cancer (PC) is generally believed to have a strong inherited component, but the ...
BACKGROUND Prostate cancer (PC) is generally believed to have a strong inherited component, but the...
Recent studies suggest that hereditary prostate cancer is a complex disease involving multiple susce...
The aggressiveness of prostate cancer (PCa) varies widely: some tumors progress to invasive, potenti...
Background: Prostate cancer represents a substantial public health burden worldwide. It is the secon...
Abstract: Background: Genetic variants are likely to contribute to a portion of prostate cancer risk...
Abstract: Background: Genetic variants are likely to contribute to a portion of prostate cancer risk...
Introduction Prostate cancer (PrCa) is the commonest non-cutaneous cancer in men in the UK. Epidemio...